Halozyme Therapeutics (HALO) FCF Margin Growth (3y) (2013 - 2026)
Halozyme Therapeutics (HALO) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Halozyme Therapeutics |
8.24 Bn |
7.92 Bn |
297.47 Mn |
19.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
19.00 |
| Dec 31, 2025 |
537.00 |
| Sep 30, 2025 |
1,672.00 |
| Jun 30, 2025 |
423.00 |
| Mar 31, 2025 |
1,771.00 |
| Dec 31, 2024 |
-2,188.00 |
| Sep 30, 2024 |
-6,542.00 |
| Jun 30, 2024 |
-453.00 |
| Mar 31, 2024 |
14.00 |
| Dec 31, 2023 |
-410.00 |
| Sep 30, 2023 |
5,261.00 |
| Jun 30, 2023 |
2,920.00 |
| Mar 31, 2023 |
6,617.00 |
| Dec 31, 2022 |
9,495.00 |
| Sep 30, 2022 |
9,923.00 |
| Jun 30, 2022 |
9,443.00 |
| Mar 31, 2022 |
4,846.00 |
| Dec 31, 2021 |
6,038.00 |
| Sep 30, 2021 |
18,299.00 |
| Jun 30, 2021 |
8,141.00 |
